These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 6371864

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Insulin therapy in children and adolescents with Type 1 diabetes.
    McAssey K, Perlman K, Daneman D.
    Diabetes Nutr Metab; 1999 Apr; 12(2):86-95. PubMed ID: 10554891
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N, Shashaj B.
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Why pumps? Continuous subcutaneous insulin infusion for children and adolescents with type 1 diabetes.
    Weintrob N, Shalitin S, Phillip M.
    Isr Med Assoc J; 2004 May; 6(5):271-5. PubMed ID: 15151365
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [Human insulin-induced lipoatrophy].
    Jermendy G, Nádas J, Sápi Z.
    Orv Hetil; 2000 Oct 29; 141(44):2393-6. PubMed ID: 11105557
    [Abstract] [Full Text] [Related]

  • 49. Insulin resistance in children and adolescents with type 1 diabetes mellitus: relation to obesity.
    Reinehr T, Holl RW, Roth CL, Wiesel T, Stachow R, Wabitsch M, Andler W, DPV-Wiss Study Group.
    Pediatr Diabetes; 2005 Mar 29; 6(1):5-12. PubMed ID: 15787895
    [Abstract] [Full Text] [Related]

  • 50. [Insulin allergies].
    Sola-Gazagnes A.
    Soins; 2007 Apr 29; (714 Suppl):S2, S4-5. PubMed ID: 17569273
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Continuous subcutaneous insulin infusion in type 1 diabetic Saudi children: a comparison with multiple daily insulin injections.
    Bin-Abbas B, Al-Ashwal A, Sakati N.
    Ann Saudi Med; 2006 Apr 29; 26(4):327-8. PubMed ID: 16891848
    [No Abstract] [Full Text] [Related]

  • 53. Parental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion.
    Patton SR, Dolan LM, Henry R, Powers SW.
    Pediatr Diabetes; 2007 Dec 29; 8(6):362-8. PubMed ID: 18036061
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
    Sheffield CA, Kane MP, Busch RS.
    Pharmacotherapy; 2007 Oct 29; 27(10):1449-55. PubMed ID: 17896900
    [Abstract] [Full Text] [Related]

  • 58. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
    Eugster EA, Francis G, Lawson-Wilkins Drug and Therapeutics Committee.
    Pediatrics; 2006 Oct 29; 118(4):e1244-9. PubMed ID: 17015512
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.